Pick almost any mid-size sponsor running a Phase II study today and count the systems a single subject's data actually touches. CTMS for site and monitoring management. A separate eTMF for regulatory documents. EDC for clinical data. A different vendor again for ePRO. A safety database for adverse event reporting. A spreadsheet, or a fourth vendor, for trial financials. A CRO's own portal layered on top of all of it.
That's not a worst case example. That's a fairly ordinary week for a study team, and almost none of it happened on purpose. It's the accumulated result of a decade of "best-of-breed" procurement pick the strongest point solution for each function, one function at a time without anyone stepping back to ask what happens when none of those systems were built to talk to each other.
For years, no single platform did every eClinical function well, so sponsors built their stack the same way most industries build technology stacks: one specialized tool per job. A best-in-class EDC vendor. A separate best-in-class eTMF vendor. A CTMS chosen for a different reason entirely, sometimes inherited from a CRO relationship or a prior study. Each decision made sense in isolation. None of them were made with the others in mind.
The result is a study where the same subject exists as a separate record in six or seven places, none of which automatically know what the others contain.
Redundant data entry. The same information a site's contact details, a subject's enrollment status, a document's approval date gets entered manually into multiple systems because there's no shared data model connecting them.
Reconciliation becomes a full-time function. Someone has to periodically check that CTMS, eTMF, and EDC agree with each other, because nothing enforces that agreement automatically. That reconciliation work scales with every system added to the stack, not just with study size.
Real-time oversight becomes structurally impossible. A risk signal that shows up in EDC a spike in a specific adverse event term, a pattern of missed visits doesn't automatically connect to what's happening in CTMS or the safety database. Someone has to notice the pattern across systems manually, which means it's noticed late.
The audit trail fragments with the systems. An inspector or auditor tracing a single decision why a subject was randomized, who approved a protocol deviation has to pull records from multiple vendors with different logging standards, different timestamp formats, and different access histories, instead of following one continuous trail.
Total cost of ownership compounds quietly. Beyond license fees, every additional system means another integration to maintain, another vendor relationship to manage, another security review, another training curriculum for site staff who now need credentials across five or six platforms just to run one study.
ICH E6(R3)'s emphasis on risk-based quality management depends on being able to see risk signals as they emerge, across the full picture of a trial not just within whichever single system happens to be open at the time. A sponsor that can only see EDC data in EDC, safety signals in a separate safety database, and site performance in a third system is running exactly the kind of siloed oversight the guidance is pushing the industry away from. Real-time, risk-based monitoring assumes the data is actually connected. Fragmented systems make that assumption false by default.
A complete eClinical suite isn't a bundle of separate products sold together it's CTMS, eTMF, EDC, ePRO/eCOA, RTSM, CTFM, and Safety & Pharmacovigilance sharing one data model, one audit trail, and one set of access controls, so a subject, a site, or a document exists as a single record everywhere it's referenced instead of a separate copy in every system that touches it.
| Fragmented point-solution stack | Unified eClinical suite | |
|---|---|---|
| Subject record | Separate entry in each system | Single record referenced everywhere |
| Cross-functional risk visibility | Manual, after the fact | Built into shared dashboards |
| Audit trail | Fragmented across vendors | One continuous trail |
| New site or user onboarding | Credentials and training per system | One platform, one access model |
| Reconciliation effort | Ongoing manual work | Structurally unnecessary |
Clinical operations gets one place to see site status, monitoring visit history, and study progress instead of toggling between systems to assemble the full picture.
QA and regulatory get an audit trail that stays continuous instead of stitched together from multiple vendor logs during an inspection.
Data management reconciles against a single source of record instead of manually cross-referencing exports from disconnected systems.
Finance sees study spend, site payments, and operational status in the same place instead of managing trial financials as a separate exercise from clinical progress.
Cloudbyz was built as a single, Salesforce-native eClinical platform from the start CTMS, eTMF, EDC with integrated ePRO/eCOA, CTFM, RTSM, and Safety & Pharmacovigilance running on one shared data model rather than stitched together through point-to-point integrations after the fact.
See how a unified eClinical platform replaces a fragmented system stack book a demo with our team.